Polycystic Ovary Syndrome Clinical Trials

Find Polycystic Ovary Syndrome Clinical Trials Near You

Comparison of Inositol and Metformin Administration in Mediterranean Diet and Low-Carbohydrate Diets in Women With Polycystic Ovary Syndrome

Status: Recruiting
Location: See location...
Intervention Type: Other, Dietary supplement, Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Polycystic ovary syndrome (PCOS) is a common endocrine disorder frequently associated with obesity, insulin resistance (IR), and metabolic dysfunction. Although lifestyle modification is recommended as first-line therapy, the optimal dietary approach for women with PCOS remains uncertain. This randomized, controlled, open-label, parallel-group trial aims to compare the effects of a Mediterranean diet (MD) and a low-carbohydrate diet (LCD), each combined with metformin, inositol, or folic acid (active control), in obese women with PCOS and IR. A total of 102 participants will be randomly assigned to one of six intervention groups and followed for two months. Anthropometric measurements, body composition, biochemical parameters, and hedonic hunger will be assessed at baseline and after the intervention. The primary outcome is the change in insulin resistance, assessed by the Homeostatic Model Assessment for Insulin Resistance (HOMA-IR), from baseline to 2 months. Secondary outcomes include changes in body composition, metabolic and biochemical parameters, and hedonic hunger.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 20
Maximum Age: 40
Healthy Volunteers: f
View:

• Women aged 20-40

• Diagnosed with PCOS (Rotterdam, 2004)

• Insulin resistant (newly diagnosed or diagnosed within the last 3 months)

• Obese according to the World Health Organization (2006) in grades 1 and 2 (BMI: 30-40 kg/m²)

Locations
Other Locations
Turkey
Dicle University Hospital
RECRUITING
Diyarbakır
Contact Information
Primary
Esra Ucar, MSc
esra.ucar@dicle.edu.tr
+90 555 993 1894
Time Frame
Start Date: 2026-08-13
Estimated Completion Date: 2027-09
Participants
Target number of participants: 90
Treatments
Experimental: Group Receiving Mediterranean Diet and Inositol Supplement
Participants in this arm will receive a hypocaloric Mediterranean diet combined with a myo-inositol supplement containing folic acid. The supplement will be administered orally as two sachets daily, providing a total daily dose of 4000 mg myo-inositol and 400 µg folic acid. The intervention period will be 2 months.
Experimental: Group Receiving Mediterranean Diet and Metformin Treatment
Participants in this arm will receive a hypocaloric Mediterranean diet combined with metformin and folic acid supplementation. Metformin will be administered orally at a dose of 500 mg once daily during the first week and increased to 1000 mg/day (500 mg twice daily) from the second week onward, as tolerated. Folic acid will be administered orally at a dose of 400 µg once daily. Folic acid is included to standardize folate intake across intervention groups, as the myo-inositol supplement used in the inositol groups also contains folic acid. The intervention period will be 2 months.
Active_comparator: Mediterranean Diet Active Control Group
Participants in this arm will receive a hypocaloric Mediterranean diet together with folic acid supplementation. Folic acid will be administered orally at a dose of 400 µg once daily. No metformin or myo-inositol supplementation will be provided. Folic acid is included to standardize folate intake across intervention groups, as the myo-inositol supplement used in the inositol groups also contains folic acid. The intervention period will be 2 months.
Experimental: Group Receiving Low-Carbohydrate Diet and Inositol Supplement
Participants in this arm will receive a hypocaloric low-carbohydrate diet combined with a myo-inositol supplement containing folic acid. The supplement will be administered orally as two sachets daily, providing a total daily dose of 4000 mg myo-inositol and 400 µg folic acid. The intervention period will be 2 months.
Experimental: Group Receiving Low-Carbohydrate Diet and Metformin Treatment
Participants in this arm will receive a hypocaloric low-carbohydrate diet combined with metformin and folic acid supplementation. Metformin will be administered orally at a dose of 500 mg once daily during the first week and increased to 1000 mg/day (500 mg twice daily) from the second week onward, as tolerated. Folic acid will be administered orally at a dose of 400 µg once daily. Folic acid is included to standardize folate intake across intervention groups, as the myo-inositol supplement used in the inositol groups also contains folic acid. The intervention period will be 2 months.
Active_comparator: Low-Carbohydrate Diet Active Control Group
Participants in this arm will receive a hypocaloric low-carbohydrate diet together with folic acid supplementation. Folic acid will be administered orally at a dose of 400 µg once daily. No metformin or myo-inositol supplementation will be provided. Folic acid is included to standardize folate intake across intervention groups, as the myo-inositol supplement used in the inositol groups also contains folic acid. The intervention period will be 2 months.
Sponsors
Leads: Dicle University

This content was sourced from clinicaltrials.gov